CMS Opens Door to Coverage of Comprehensive Genomic Sequencing

In The Headlines: Are cancer registries on the chopping block, and what does it mean if they are?

The National Cancer Registries Program, or NPCR, is a relatively small but highly impactful 33-year-old CDC program that gauges disparities in cancer and tracks progress against the disease. So, why was it left out of the Trump administration’s preliminary budget?

April 30, 2025

Vol.51 No.16

Conversation with The Cancer Letter

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

Over the past seven years, as Steven K. Libutti was designing the 12-story, $900-plus million cancer hospital in New Brunswick, NJ, he often thought of the functionality of the building that inspired it: Building 10, the NIH Clinical Center.

In her own words: Rathmell reflects on her priorities and values—and encourages everyone to do the same

I did not find the process of being suddenly without employment as refreshing as one might think. It did, however, provide a forced opportunity to engage in self-reflection, to critically analyze the situation around cancer, and to face the complex set of problems that cancer, and society, present to us.

April 25, 2025

Vol.51 No.16

By W. Kimryn Rathmell

Regulatory News

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models.

April 25, 2025

Vol.51 No.16

By Claire Marie Porter

Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI

We are at a transformational period in oncology; the overall mortality from cancer is gradually declining in the United States.

April 25, 2025

Vol.51 No.16

By Suresh S. Ramalingam and Adam Marcus

Advancing peritoneal oncology: Innovations in surgical strategies and research

Peritoneal metastases arise from gastrointestinal and gynecologic malignancies, leading to debilitating symptoms and poor prognoses. They remain one of the most challenging manifestations of advanced malignancies, often leading to significant morbidity and limited treatment options.

April 25, 2025

Vol.51 No.16

By Mustafa Raoof

CMS Opens Door to Coverage of Comprehensive Genomic Sequencing

YOU MAY BE INTERESTED IN

In The Headlines: Are cancer registries on the chopping block, and what does it mean if they are?

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

In her own words: Rathmell reflects on her priorities and values—and encourages everyone to do the same

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI

Advancing peritoneal oncology: Innovations in surgical strategies and research

Renew today!

Subscriber content

Never miss an issue!

Login

CMS Opens Door to Coverage of Comprehensive Genomic Sequencing

YOU MAY BE INTERESTED IN

In The Headlines: Are cancer registries on the chopping block, and what does it mean if they are?

Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health

In her own words: Rathmell reflects on her priorities and values—and encourages everyone to do the same

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industryCommissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas

Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI

Advancing peritoneal oncology: Innovations in surgical strategies and research

Never miss an issue!

Login

Makary vows to speed up drug approvals and end FDA’s “cozy” relationship with industry
Commissioner promises to protect scientific integrity while bringing in “fresh” MAHA ideas